Latest News

Distribution Solutions Group (DSGR) has welcomed Sean Dwyer as its new Senior Vice President, Head of M&A and Strategy. Dwyer's appointment highlights the company’s ongoing commitment to strengthening its strategic leadership team. See our latest analysis for Distribution Solutions Group. The leadership shakeup comes in the wake of other recent moves, including an expanded buyback plan and a high-profile conference appearance. Despite these efforts, Distribution Solutions Group’s 1-year total...

In late November 2025, a Politico report revealed that the White House intends to propose a two-year extension of Obamacare subsidies, a move anticipated to bolster sustained patient enrollment for healthcare companies like Surgery Partners. This development could help maintain a core revenue stream for outpatient surgery centers, directly influencing long-term business stability in the sector. We'll now explore how anticipation of extended Obamacare subsidies could impact Surgery Partners’...

Baycurrent (TSE:6532) announced on November 19 that President Daisuke Kitakaze has resigned to focus on medical treatment. Yoshiyuki Abe will step in as the new President and Chairman. Executive changes like this often attract close attention from investors, especially when they affect leadership continuity. See our latest analysis for Baycurrent. Kitakaze’s departure and Abe’s immediate appointment come at a time when Baycurrent’s share price has seen strong momentum in 2024. The stock is...

Caesars Entertainment (CZR) stock has faced heavy selling pressure after being removed from the S&P 500. This change was triggered by its falling market capitalization and broader investor concern about ongoing operational challenges. Persistent weakness in its Las Vegas and regional casino properties has added to the pressure, raising questions about the company's next steps in navigating these headwinds. See our latest analysis for Caesars Entertainment. This stretch of losses has weighed...

Power Corporation of Canada (TSX:POW) has completed a fixed-income offering and issued CAD 150 million in 5.65% preferred shares. This new batch of non-convertible preferred shares adds to their capital base and could attract interest from income-focused investors. See our latest analysis for Power Corporation of Canada. Power Corporation of Canada’s share price has gathered impressive momentum throughout 2024, with a robust year-to-date share price return of 63.14% and a 60.14% total...

In the past week, Dutch Bros reported third-quarter results that surpassed analyst expectations and raised its 2025 revenue guidance, citing improved same-store sales projections despite sustained cost pressures. An interesting development is Dutch Bros' move to expand its breakfast menu pilot nationally, aiming for a full rollout by the end of 2026 to strengthen its position in the morning beverage and food segment. We'll examine how upbeat quarterly results and a national breakfast menu...

Hawaiian Electric (HE) is refreshing its public EV charging stations with new branding, upgraded fast-charging equipment, and expanded locations, following recent regulatory backing. These moves highlight the company’s evolving strategy as Hawaii's electric vehicle market experiences rapid growth. See our latest analysis for Hawaiian Electric Industries. HE’s EV network upgrade arrives during a period of rebuilding momentum for the stock. Despite a tough stretch marked by a three-year total...

Earlier this week, Tesla announced a partnership with XPEL to offer OEM-approved window tinting services and combined warranty coverage for Tesla vehicles in the US, while XPEL reported third-quarter 2025 revenue above analyst forecasts but an earnings per share miss, alongside plans for up to US$150 million in capital investments over the next two years. This collaboration gives XPEL direct access to Tesla's customer base and underscores strong industry recognition of XPEL's products by a...

Corcept Therapeutics (CORT) has adjusted its revenue outlook for 2025, citing capacity constraints with a previous specialty pharmacy vendor. This adjustment comes as new prescriptions for Korlym continue to increase in its hypercortisolism segment. See our latest analysis for Corcept Therapeutics. Corcept’s revenue guidance revision comes after strong momentum in both its core business and share price. Despite recent insider selling and mixed third-quarter results, the stock has delivered a...

Builders FirstSource (BLDR) is catching attention among value-focused investors as the stock continues to trade at a discount compared to its industry peers. Recent activity points to renewed optimism surrounding its near-term potential. See our latest analysis for Builders FirstSource. Despite some turbulence, Builders FirstSource has seen its share price rebound 9.97% over the past seven days and is now trading at $111.75. While the 1-year total shareholder return stands at -40.07%, its...

Curtiss-Wright Corporation recently declared a quarterly dividend of US$0.24 per share payable on December 12, 2025, and increased its share buyback authorization by US$416 million, raising the total authorization to US$2.07 billion. These capital management decisions highlight both confidence in the company’s outlook and a continued commitment to returning value to shareholders. We’ll explore how Curtiss-Wright’s expanded US$2.07 billion buyback program strengthens its investment narrative...

Graham Holdings recently completed a US$400 million five-year revolving credit facility and issued US$500 million in senior unsecured notes due 2033, aimed at refinancing existing debt and enhancing financial flexibility. This debt restructuring plan replaces upcoming maturities and expands the company’s access to capital on improved financial terms, underscoring a significant shift in its balance sheet management. We’ll explore how Graham Holdings’ increased access to flexible funding...

Ever wondered whether Norfolk Southern is trading at a fair price or if there is a hidden opportunity waiting for careful investors? Here's what you need to know. The stock has climbed 23.6% so far this year, giving it strong momentum and drawing attention from those watching upward trends. Recently, headlines have focused on industry developments, including infrastructure spending bills and transportation policy discussions. These factors can influence investor sentiment for rail companies...

Cmb.Tech (ENXTBR:CMBT) is in the spotlight after posting its Q3 2025 results. The company delivered a profit, added seven new ships as part of its decarbonisation push, and announced an interim dividend for shareholders. See our latest analysis for Cmb.Tech. Cmb.Tech’s stock has bounced back with momentum, as shown by an 18.3% share price return over the last month and nearly 30% in the past quarter. Although the longer-term total shareholder return remains negative over one and three years,...

Earlier this week, TD Cowen analyst James Schumm downgraded PureCycle Technologies to a hold rating, reflecting a shift in outlook towards the company's shares. Analyst rating changes such as this can influence investor sentiment and are often closely monitored as indicators of changing perspectives within the financial community. We’ll explore how this analyst downgrade shapes PureCycle Technologies’ investment narrative, especially in light of its recent share price reaction. AI is about...

Aroa Biosurgery Limited ( ASX:ARX ) last week reported its latest half-yearly results, which makes it a good time for...

Insiders who bought AU$200.0k worth of Blue Energy Limited's ( ASX:BLU ) stock at an average buy price of AU$0.005 over...

Even if it's not a huge purchase, we think it was good to see that David Schwartz, the Non-Executive Independent...

IDP Education's (ASX:IEL) stock is up by a considerable 8.9% over the past week. But the company's key financial...

Rémy Cointreau (ENXTPA:RCO) just posted its latest H1 2026 results, delivering total revenue of €450.9 million and basic EPS of €0.56, with net income (excluding extra items) coming in at €29.2 million. Over the last several half-year periods, the company has seen revenue fall from €557.4 million in H2 2024 to €533.7 million in H1 2025, and now to €450.9 million. Basic EPS shifted from €1.41 to €1.81, before landing at €0.56. Margins compressed as profit declined, underscoring a challenging...

Earlier this week, CRISPR Therapeutics reported quarterly results that surpassed expectations, driven by reduced R&D spending and encouraging clinical progress, including positive Phase 1 data for CTX310 and advancements in SyNTase gene editing technology. This momentum, coupled with upward revisions in earnings estimates despite ongoing losses, has sparked heightened investor interest and renewed analyst confidence in the company's pipeline developments. We'll explore how CTX310's Phase 1...

VGP (ENXTBR:VGP) shares have held steady recently. The company continues to focus on its core business of logistics and semi-industrial real estate across Europe. Investors have been watching for updates that could influence future moves. See our latest analysis for VGP. VGP’s share price has climbed 43.7% so far this year. A steady 6.3% gain over the past three months suggests some momentum is building as investors respond to ongoing growth in its logistics real estate portfolio. Over the...

Saniona (OM:SANION) just posted its Q3 2025 results, reporting total revenue of 410.7 million SEK and basic EPS of 2.39 SEK, reflecting a solid headline performance. Over the past twelve months, revenue grew from 334.7 million SEK to 743.2 million SEK, while EPS climbed from 1.77 SEK to 4.64 SEK, marking a sharp uptick in profitability. Margins continued to stand out, with net income delivering a notable boost to the bottom line. See our full analysis for Saniona. Now let's put these results...

UBM Development (WBAG:UBS) just posted its Q3 2025 results, reporting revenue of €35.1 million and net income of €1.7 million. For context, the company has seen revenue climb from €20.5 million in Q3 2024 to €35.1 million in the latest quarter. Net income improved from a loss of €4.6 million last year to a positive €1.7 million this quarter. Margins remain a focus for investors, with the turnaround in profitability providing fresh perspective for the current reporting period. See our full...